Skip to main content
Fig. 7 | Journal of Nanobiotechnology

Fig. 7

From: NIR responsive tumor vaccine in situ for photothermal ablation and chemotherapy to trigger robust antitumor immune responses

Fig. 7

Immune responses assessment in vivo. a Scheme and timeline of the experimental design to evaluate the in vivo immune responses triggered by HA-PDA@IQ/DOX HG treatment. b Representative flow cytometry plots and statistic data c of CD80+ or CD86+ among CD11c+ DCs extracted from the inguinal lymph nodes (LNs). d Representative flow cytometry plots and statistic data e illustrated memory T cell in inguinal lymph nodes (LNs). f Representative flow cytometry plots and statistic data g of CD3+CD8a+T cells in spleen. p values were calculated by the Student’s t test. Mean ± SD (n = 4) of three independent experiments, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.001

Back to article page